Walmart Reaches Settlement With US Government
The Walmart opioid lawsuit settlement has ended a major US government case against the country’s largest retailer. The Justice Department accused Walmart of allowing its pharmacies to improperly dispense opioid prescriptions and other controlled substances.
The Justice Department and Walmart confirmed the settlement on Friday. Neither side disclosed the financial or other terms of the agreement.
Federal prosecutors filed the original lawsuit in 2020. They alleged that Walmart repeatedly violated the Controlled Substances Act from 2013 onward. The government said the case could have exposed the retailer to billions of dollars in civil penalties.
Case Focused on Pharmacy Practices
The lawsuit focused on how Walmart pharmacies handled prescriptions for opioids and other controlled drugs. Prosecutors argued that the company failed to meet its legal responsibilities when dispensing certain prescriptions.
A federal court in Wilmington, Delaware, received a joint filing to dismiss the case on Thursday. The filing formally brings the dispute to an end.
The Justice Department said the settlement resolves allegations that Walmart pharmacies failed to follow their obligations under federal law.
Walmart said it was pleased to resolve the matter. The company also praised its pharmacists and said they would continue to focus on patient care.
Opioid Crisis Remains a Major US Issue
The case comes against the backdrop of a long-running opioid crisis in the United States. More than 905,000 people died from opioid overdoses between 1999 and 2025, according to the US Centers for Disease Control and Prevention.
Annual overdose deaths began falling after 2022. However, opioid-related harm remains a major public health concern across the country.
The Walmart case ranked among the Justice Department’s most significant legal actions against an individual company linked to the crisis.
Court Narrowed the Lawsuit
The case changed significantly during the court proceedings. In March 2024, US District Judge Colm Connolly dismissed some of the government’s claims.
The judge rejected allegations that Walmart failed to report suspicious prescriptions to the Drug Enforcement Administration. He also dismissed claims involving pharmacists’ documentation of warning signs connected to prescriptions.
However, the court allowed the government to continue pursuing claims involving prescriptions that Walmart compliance personnel allegedly knew were invalid.
Walmart Previously Paid $3.1 Billion
The latest settlement is separate from Walmart’s earlier agreements with state and local governments.
In 2022, Walmart agreed to pay $3.1 billion to resolve thousands of lawsuits linked to its pharmacies and the opioid crisis. CVS and Walgreens also reached major settlements over their alleged roles in opioid distribution.
Walmart shares rose about 0.5% in morning trading following news of the latest settlement.
The agreement closes another major legal dispute surrounding the retailer while keeping attention on the responsibilities of pharmacies that dispense powerful prescription drugs.
